litlas
Log inCreate account

Peter C. Butler

Active 1989–2022

81
Papers
21,852
Citations
72
h-index
81
i10-index

Citations

Citations per year for Peter C. Butler1974: 1 citations1990: 1 citations1991: 7 citations1992: 8 citations1993: 4 citations1994: 5 citations1995: 7 citations1996: 5 citations1997: 11 citations1998: 11 citations1999: 12 citations2000: 34 citations2001: 37 citations2002: 39 citations2003: 86 citations2004: 122 citations2005: 123 citations2006: 210 citations2007: 213 citations2008: 342 citations2009: 335 citations2010: 294 citations2011: 282 citations2012: 299 citations2013: 378 citations2014: 329 citations2015: 299 citations2016: 240 citations2017: 255 citations2018: 205 citations2019: 587 citations2020: 584 citations2021: 643 citations2022: 463 citations2023: 280 citations2024: 454 citations2025: 210 citations2026: 7 citations1975–1989: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 2,245 citing papers, 29.6% of this breakdownChina: 555 citing papers, 7.3% of this breakdownUnited Kingdom: 488 citing papers, 6.4% of this breakdownItaly: 373 citing papers, 4.9% of this breakdownGermany: 334 citing papers, 4.4% of this breakdownCanada: 300 citing papers, 4% of this breakdownJapan: 222 citing papers, 2.9% of this breakdownSweden: 213 citing papers, 2.8% of this breakdownDenmark: 203 citing papers, 2.7% of this breakdownIndia: 192 citing papers, 2.5% of this breakdownAustralia: 184 citing papers, 2.4% of this breakdownSwitzerland: 182 citing papers, 2.4% of this breakdown
0%29.6%Other 27.7%

Institutions

Fields

  • Medicine74.5%
  • Biochemistry, Genetics and Molecular Biology17.4%
  • Neuroscience3.2%
  • Pharmacology, Toxicology and Pharmaceutics0.9%
  • Nursing0.7%
  • Immunology and Microbiology0.5%
  • Other2.8%

Topics

  • Pancreatic function and diabetes13.8%
  • Diabetes and associated disorders6.1%
  • Alzheimer's disease research and treatments6.1%
  • Diabetes Treatment and Management5.2%
  • Metabolism, Diabetes, and Cancer4.4%
  • Diabetes Management and Research4.2%
  • Other60.2%

Coauthors

All papers

Open in search
  1. β-Cell Deficit and Increased β-Cell Apoptosis in Humans With Type 2 Diabetes

    Authors: Alexandra E. Butler, Juliette Janson, Susan Bonner‐Weir, Robert Ritzel, Robert A. Rizza, Peter C. Butler - Diabetes 2003 cited by 3,990

  2. Pancreatitis, Pancreatic, and Thyroid Cancer With Glucagon-Like Peptide-1–Based Therapies

    Authors: Michael Elashoff, Aleksey V. Matveyenko, Belinda Gier, Robert M. Elashoff, Peter C. Butler - Gastroenterology 2011 cited by 931

  3. Increased Risk of Type 2 Diabetes in Alzheimer Disease

    Authors: Juliette Janson, Thomas Laedtke, Joseph E. Parisi, Peter C. O’Brien, Ronald C. Petersen, Peter C. Butler - Diabetes 2004 cited by 956

  4. Fibril specific, conformation dependent antibodies recognize a generic epitope common to amyloid fibrils and fibrillar oligomers that is absent in prefibrillar oligomers

    Authors: Rakez Kayed, Elizabeth Head, Floyd Sarsoza, Tommy Saing, Carl W. Cotman, Mihaela Necula, Lawrence Margol, Jessica Wu, Leonid Breydo, Jennifer L. Thompson, Suhail Rasool, Tatyana Gurlo, Peter C. Butler, Charles Glabe - Molecular Neurodegeneration 2007 cited by 782

  5. Type 2 diabetes as a protein misfolding disease

    Authors: Abhisek Mukherjee, Diego Morales‐Scheihing, Peter C. Butler, Claudio Soto - Trends in Molecular Medicine 2015 cited by 341

  6. Glucagon Like Peptide-1 Receptor Expression in the Human Thyroid Gland

    Authors: Belinda Gier, Peter C. Butler, Chi Lai, David Kirakossian, Matthew DeNicola, Michael W. Yeh - The Journal of Clinical Endocrinology & Metabolism 2011 cited by 148

  7. Chronic GLP-1 Receptor Activation by Exendin-4 Induces Expansion of Pancreatic Duct Glands in Rats and Accelerates Formation of Dysplastic Lesions and Chronic Pancreatitis in the KrasG12D Mouse Model

    Authors: Belinda Gier, Aleksey V. Matveyenko, David Kirakossian, David D. Dawson, Sarah Dry, Peter C. Butler - Diabetes 2012 cited by 248

  8. Pancreas volumes in humans from birth to age one hundred taking into account sex, obesity, and presence of type‐2 diabetes

    Authors: Yoshifumi Saisho, Alexandra E. Butler, Juris J. Meier, Travis Monchamp, Martin Allen-Auerbach, R. A. Rizza, Peter C. Butler - Clinical Anatomy 2007 cited by 469

  9. Marked Expansion of Exocrine and Endocrine Pancreas With Incretin Therapy in Humans With Increased Exocrine Pancreas Dysplasia and the Potential for Glucagon-Producing Neuroendocrine Tumors

    Authors: Alexandra E. Butler, Martha Campbell‐Thompson, Tatyana Gurlo, David W. Dawson, Mark A. Atkinson, Peter C. Butler - Diabetes 2013 cited by 451

  10. Adaptive changes in pancreatic beta cell fractional area and beta cell turnover in human pregnancy

    Authors: Alexandra E. Butler, L. Cao-Minh, Rocco Galasso, R. A. Rizza, Alberto Corradin, Claudio Cobelli, Peter C. Butler - Diabetologia 2010 cited by 425

  11. β-Cell Replication Is the Primary Mechanism Subserving the Postnatal Expansion of β-Cell Mass in Humans

    Authors: Juris J. Meier, Alexandra E. Butler, Yoshifumi Saisho, Travis Monchamp, Ryan Galasso, Anil Bhushan, Robert A. Rizza, Peter C. Butler - Diabetes 2008 cited by 686

  12. β-Cell Mass and Turnover in Humans

    Authors: Yoshifumi Saisho, Alexandra E. Butler, Erica Manesso, David Elashoff, Robert A. Rizza, Peter C. Butler - Diabetes Care 2012 cited by 399

  13. A Critical Analysis of the Clinical Use of Incretin-Based Therapies

    Authors: Peter C. Butler, Michael Elashoff, Robert M. Elashoff, Edwin Gale - Diabetes Care 2013 cited by 296

  14. Pulsatile insulin secretion, impaired glucose tolerance and type 2 diabetes

    Authors: Leslie S. Satin, Peter C. Butler, Joon Ha, Arthur Sherman - Molecular Aspects of Medicine 2015 cited by 239

  15. Islet Amyloid in Type 2 Diabetes, and the Toxic Oligomer Hypothesis

    Authors: Leena Haataja, Tatyana Gurlo, Chang Jiang Huang, Peter C. Butler - Endocrine Reviews 2008 cited by 602

  16. The cancer preventative agent resveratrol is converted to the anticancer agent piceatannol by the cytochrome P450 enzyme CYP1B1

    Authors: Gerard A. Potter, L. H. Patterson, E Wanogho, J. Jefferson P. Perry, Peter C. Butler, Taeeba Ijaz, Ketan C. Ruparelia, John H. Lamb, P. B. Farmer, Lesley A. Stanley, M.D. Burke - British Journal of Cancer 2002 cited by 375

  17. Activation of the HIF1α/PFKFB3 stress response pathway in beta cells in type 1 diabetes

    Authors: Hiroshi Nomoto, Lina Pei, Chiara Montemurro, Madeline Rosenberger, Allison Furterer, Giovanni Coppola, Brian B. Nadel, Matteo Pellegrini, Tatyana Gurlo, Peter C. Butler, Slavica Tudzarova - Diabetologia 2019 cited by 68

  18. Sustained beta cell apoptosis in patients with long-standing type 1 diabetes: indirect evidence for islet regeneration?

    Authors: Juris J. Meier, Anil Bhushan, Alexandra E. Butler, R. A. Rizza, Peter C. Butler - Diabetologia 2005 cited by 491

  19. Autophagy defends pancreatic β cells from human islet amyloid polypeptide-induced toxicity

    Authors: Jacqueline F. Rivera, Safia Costes, Tatyana Gurlo, Charles Glabe, Peter C. Butler - Journal of Clinical Investigation 2014 cited by 205

  20. Live-cell imaging of glucose-induced metabolic coupling of β and α cell metabolism in health and type 2 diabetes

    Authors: Zhongying Wang, Tatyana Gurlo, Aleksey V. Matveyenko, David Elashoff, Peiyu Wang, Madeline Rosenberger, Jason A. Junge, Raymond C. Stevens, Kate L. White, Scott E. Fraser, Peter C. Butler - Communications Biology 2021 cited by 42

  21. IAPP toxicity activates HIF1α/PFKFB3 signaling delaying β-cell loss at the expense of β-cell function

    Authors: Chiara Montemurro, Hiroshi Nomoto, Lina Pei, Vishal S. Parekh, Kenny Vongbunyong, Suryakiran Vadrevu, Tatyana Gurlo, Alexandra E. Butler, Rohan Subramaniam, Eleni Ritou, Orian S. Shirihai, Leslie S. Satin, Peter C. Butler, Slavica Tudzarova - Nature Communications 2019 cited by 87

  22. High Expression Rates of Human Islet Amyloid Polypeptide Induce Endoplasmic Reticulum Stress–Mediated β-Cell Apoptosis, a Characteristic of Humans With Type 2 but Not Type 1 Diabetes

    Authors: Chang-jiang Huang, Chia‐Yu Lin, Leena Haataja, Tatyana Gurlo, Alexandra E. Butler, Robert A. Rizza, Peter C. Butler - Diabetes 2007 cited by 410

  23. Reversing type 1 diabetes with stem cell–derived islets: a step closer to the dream?

    Authors: Peter C. Butler, Edwin Gale - Journal of Clinical Investigation 2022 cited by 19

  24. Relationship between β‐cell mass and diabetes onset

    Authors: Aleksey V. Matveyenko, Peter C. Butler - Diabetes Obesity and Metabolism 2008 cited by 244